These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12205069)

  • 1. Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model.
    Fuursted K; Schumacher H
    J Antimicrob Chemother; 2002 Sep; 50(3):421-4. PubMed ID: 12205069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
    Kim J; Jo A; Chukeatirote E; Ahn J
    Ann Clin Microbiol Antimicrob; 2016 Dec; 15(1):60. PubMed ID: 27938381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane proteins of Klebsiella pneumoniae after exposure to ciprofloxacin.
    Hostacká A; Karelová E
    Zentralbl Bakteriol; 1998 May; 287(4):343-6. PubMed ID: 9638864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
    J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Szabó D; Máthé A; Lengyel J; Anderlik P; Rókusz L; Rozgonyi F
    Curr Med Chem; 2002 Feb; 9(4):437-42. PubMed ID: 11945119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Rydberg J; Larsson C; Miörner H
    Scand J Infect Dis; 1994; 26(3):317-20. PubMed ID: 7939432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.
    Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH; Firsov AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1208-15. PubMed ID: 26643328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1809-15. PubMed ID: 3324962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
    Paterson DL; Mulazimoglu L; Casellas JM; Ko WC; Goossens H; Von Gottberg A; Mohapatra S; Trenholme GM; Klugman KP; McCormack JG; Yu VL
    Clin Infect Dis; 2000 Mar; 30(3):473-8. PubMed ID: 10722430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
    Coban AY; Bayram Z; Sezgin FM; Durupinar B
    Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
    Rodríguez-Martínez JM; Pichardo C; García I; Pachón-Ibañez ME; Docobo-Pérez F; Pascual A; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jul; 14(7):691-7. PubMed ID: 18558942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance.
    Aathithan S; French GL
    Int J Antimicrob Agents; 2010 Sep; 36(3):239-42. PubMed ID: 20541915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
    Anderl JN; Franklin MJ; Stewart PS
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1818-24. PubMed ID: 10858336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes of Ciprofloxacin-Resistant Klebsiella pneumoniae in Korea and Their Characteristics According to the Genetic Lineages.
    Park DJ; Yu JK; Park KG; Park YJ
    Microb Drug Resist; 2015 Dec; 21(6):622-30. PubMed ID: 26207318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage of ciprofloxacin resistance with a single genotypic cluster of Klebsiella pneumoniae.
    Dashti AA; Paton R; Amyes SG
    Int J Antimicrob Agents; 2006 Jan; 27(1):73-6. PubMed ID: 16321509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
    Hostacká A
    Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.
    Strahilevitz J; Engelstein D; Adler A; Temper V; Moses AE; Block C; Robicsek A
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3001-3. PubMed ID: 17526754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.
    Kesteman AS; Ferran AA; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4740-8. PubMed ID: 19738020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.